Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AcceleRatEd vs. StandarD ContinUous Renal ReplaCement ThErapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator: Randomized-Controlled Trial

NCT06696235 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06696235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AcceleRatEd vs. StandarD ContinUous Renal ReplaCement ThErapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator: Randomized-Controlled Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
December 31, 2024
Completion date
June 30, 2029
Enrollment
408 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiogenic shock